185 related articles for article (PubMed ID: 38217425)
1. Neuropsychiatric manifestations of tuberous sclerosis in a young man in a psychiatric hospital in Botswana: a case report.
Chabalala WT; Bojosi K; Maphane T; Olashore AA
J Int Med Res; 2024 Jan; 52(1):3000605231223450. PubMed ID: 38217425
[TBL] [Abstract][Full Text] [Related]
2. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation.
Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK
Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612
[TBL] [Abstract][Full Text] [Related]
3. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
4. Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings.
Caylor RC; Grote L; Thiffault I; Farrow EG; Willig L; Soden S; Amudhavalli SM; Nopper AJ; Horii KA; Fleming E; Jenkins J; Welsh H; Ilyas M; Engleman K; Abdelmoity A; Saunders CJ
Neurogenetics; 2018 Aug; 19(3):205-213. PubMed ID: 29926239
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genotypes and phenotypes in Chinese children with tuberous sclerosis complex.
Bai D; Zhao J; Li L; Gao J; Wang X
Sci China Life Sci; 2017 Jul; 60(7):763-771. PubMed ID: 28623545
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice.
Koike-Kumagai M; Fujimoto M; Wataya-Kaneda M
Neuropharmacology; 2022 Nov; 218():109203. PubMed ID: 35931213
[TBL] [Abstract][Full Text] [Related]
7. A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex.
Mammadova D; Vecko J; Hofmann M; Schüssler SC; Deiters L; Canda A; Wieland AK; Gollwitzer S; Hamer H; Trollmann R
Orphanet J Rare Dis; 2023 Nov; 18(1):349. PubMed ID: 37946245
[TBL] [Abstract][Full Text] [Related]
8. Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways-Case Report and Literature Review.
Jurca CM; Kozma K; Petchesi CD; Zaha DC; Magyar I; Munteanu M; Faur L; Jurca A; Bembea D; Severin E; Jurca AD
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833359
[TBL] [Abstract][Full Text] [Related]
9. Electro-clinical and neurodevelopmental outcome in six children with early diagnosis of tuberous sclerosis complex and role of the genetic background.
Savini MN; Mingarelli A; Peron A; La Briola F; Cervi F; Alfano RM; Canevini MP; Vignoli A
Ital J Pediatr; 2020 Mar; 46(1):36. PubMed ID: 32216820
[TBL] [Abstract][Full Text] [Related]
10. New developments in the neurobiology of the tuberous sclerosis complex.
Crino PB; Henske EP
Neurology; 1999 Oct; 53(7):1384-90. PubMed ID: 10534239
[TBL] [Abstract][Full Text] [Related]
11. [Tuberous sclerosis complex: A review].
Pfirmann P; Combe C; Rigothier C
Rev Med Interne; 2021 Oct; 42(10):714-721. PubMed ID: 33836894
[TBL] [Abstract][Full Text] [Related]
12. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.
Peron A; Vignoli A; Briola F; Morenghi E; Tansini L; Alfano RM; Bulfamante G; Terraneo S; Ghelma F; Banderali G; Viskochil DH; Carey JC; Canevini MP;
Eur J Med Genet; 2018 Jul; 61(7):403-410. PubMed ID: 29432982
[TBL] [Abstract][Full Text] [Related]
13. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
[TBL] [Abstract][Full Text] [Related]
14. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
[TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis complex presenting as convulsive status epilepticus followed by hypoxic cerebropathy: A case report.
Liu X; Zhang Y; Hao Y; Chen Y; Chen C
Medicine (Baltimore); 2019 May; 98(19):e15545. PubMed ID: 31083211
[TBL] [Abstract][Full Text] [Related]
16. Management of Self-Injurious Behavior, Aggression, and Psychogenic Non-Epileptic Seizures in Patients With Tuberous Sclerosis: A Case Report With a Review of Literature.
Ortiz JF; Ruxmohan S; Gomez J; Lalama HA; Taylor A; Smith DW
Cureus; 2020 Nov; 12(11):e11715. PubMed ID: 33391947
[TBL] [Abstract][Full Text] [Related]
17. Neurological and neuropsychiatric aspects of tuberous sclerosis complex.
Curatolo P; Moavero R; de Vries PJ
Lancet Neurol; 2015 Jul; 14(7):733-45. PubMed ID: 26067126
[TBL] [Abstract][Full Text] [Related]
18. Tuberous Sclerosis Complex: Clinical Spectrum and Epilepsy: A Retrospective Chart Review Study.
Almobarak S; Almuhaizea M; Abukhaled M; Alyamani S; Dabbagh O; Chedrawi A; Khan S; Aldhalaan H
Transl Neurosci; 2018; 9():154-160. PubMed ID: 30479846
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel heterozygous TSC2 splicing variant in a patient with Tuberous sclerosis complex: A case report.
Liu L; Yu C; Yan G
Medicine (Baltimore); 2022 Jan; 101(3):e28666. PubMed ID: 35060563
[TBL] [Abstract][Full Text] [Related]
20. Effect of Gene Mutation on Seizures in Surgery for Tuberous Sclerosis Complex.
Chivukula S; Modiri O; Kashanian A; Babayan D; Ibrahim GM; Weil AG; Tu A; Wu JY; Mathern GW; Fallah A
Can J Neurol Sci; 2021 May; 48(3):327-334. PubMed ID: 32854808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
